These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073 [TBL] [Abstract][Full Text] [Related]
3. Changes in sexual arousal as measured by penile plethysmography in men with pedophilic sexual interest. Müller K; Curry S; Ranger R; Briken P; Bradford J; Fedoroff JP J Sex Med; 2014 May; 11(5):1221-9. PubMed ID: 24636071 [TBL] [Abstract][Full Text] [Related]
4. The long-term use of cyproterone acetate in pedophilia: a case study. Cooper AJ; Cernovsky Z; Magnus RV J Sex Marital Ther; 1992; 18(4):292-302. PubMed ID: 1291700 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Cooper AJ; Cernovsky ZZ Biol Psychiatry; 1994 Aug; 36(4):269-71. PubMed ID: 7986892 [No Abstract] [Full Text] [Related]
6. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study. Pathak AS; Pacificar JS; Shapiro CE; Williams SG J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298 [TBL] [Abstract][Full Text] [Related]
7. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Wincze JP; Bansal S; Malamud M Arch Sex Behav; 1986 Aug; 15(4):293-305. PubMed ID: 3741089 [TBL] [Abstract][Full Text] [Related]
8. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men. Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475 [TBL] [Abstract][Full Text] [Related]
9. Are pedophiles with aggressive tendencies more sexually violent? Greenberg DM; Bradford JM; Curry S Bull Am Acad Psychiatry Law; 1996; 24(2):225-35. PubMed ID: 8807162 [TBL] [Abstract][Full Text] [Related]
10. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Dickey R Can J Psychiatry; 1992 Oct; 37(8):567-9. PubMed ID: 1423159 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of the effects of gonadotropin-releasing hormone agonist therapy on brain activation pattern in a man with pedophilia. Moulier V; Fonteille V; Pélégrini-Issac M; Cordier B; Baron-Laforêt S; Boriasse E; Durand E; Stoléru S Int J Offender Ther Comp Criminol; 2012 Feb; 56(1):50-60. PubMed ID: 21518701 [TBL] [Abstract][Full Text] [Related]
12. Drug treatment of paraphilic and nonparaphilic sexual disorders. Guay DR Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704 [TBL] [Abstract][Full Text] [Related]
13. Absolute versus relative ascertainment of pedophilia in men. Blanchard R; Kuban ME; Blak T; Cantor JM; Klassen PE; Dickey R Sex Abuse; 2009 Dec; 21(4):431-41. PubMed ID: 19901237 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, controlled, clinical trial planned in germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders: presentation of the study protocol. Briken P; Berner W; Isr J Psychiatry Relat Sci; 2012; 49(4):306-13. PubMed ID: 23585468 [TBL] [Abstract][Full Text] [Related]
15. Brain pathology in pedophilic offenders: evidence of volume reduction in the right amygdala and related diencephalic structures. Schiltz K; Witzel J; Northoff G; Zierhut K; Gubka U; Fellmann H; Kaufmann J; Tempelmann C; Wiebking C; Bogerts B Arch Gen Psychiatry; 2007 Jun; 64(6):737-46. PubMed ID: 17548755 [TBL] [Abstract][Full Text] [Related]
16. LH-RH agonists modulate amygdala response to visual sexual stimulation: a single case fMRI study in pedophilia. Habermeyer B; Händel N; Lemoine P; Klarhöfer M; Seifritz E; Dittmann V; Graf M Neurocase; 2012; 18(6):489-95. PubMed ID: 22136615 [TBL] [Abstract][Full Text] [Related]
17. The latent structure of Multiphasic Sex Inventory-assessed pedophilic interest. Mackaronis JE; Strassberg DS; Marcus DK Psychol Assess; 2011 Dec; 23(4):1017-22. PubMed ID: 21767027 [TBL] [Abstract][Full Text] [Related]
18. A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer. Crawford ED; Sartor O; Chu F; Perez R; Karlin G; Garrett JS J Urol; 2006 Feb; 175(2):533-6. PubMed ID: 16406989 [TBL] [Abstract][Full Text] [Related]
19. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer. Fujii Y; Yonese J; Kawakami S; Yamamoto S; Okubo Y; Fukui I BJU Int; 2008 May; 101(9):1096-100. PubMed ID: 18190637 [TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer. Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]